BeLiver - Reinventing Treatment Selection for Better Patient Care

When biomarkers fall short, patients deserve better

Behind every tumor is a person fighting for time and quality of life, yet many cancers still lack reliable biomarkers to guide therapy.

Standard care can help, but without a truly personalized view of tumor biology it often misses what drives response, so better decisions require deeper biological insight.
‍
At BeLiver, we dig deeper into tumor biology to deliver the precision every patient deserves, because guessing isn’t an option.

Healthcare professional with a futuristic holographic projection of a liver, representing BeLiver's advanced AI-driven diagnostics for personalized liver cancer (HCC) treatment.

Transforming care by empowering oncologists with data-driven personalized decisions

BeLiver provides a clinical decision support platform that estimates each individual’s likelihood of benefit across available therapies and turns complex biological and clinical signals into clear, clinician‑ready reports.

By spotlighting options with higher probability of response, it shortens time on ineffective care and supports confident, data driven choices that can improve outcomes and patient experience.

Discover our services

High resolution proteomic profiling coupled with AI : unlocking precision oncology

High resolution proteomic profiling of tumor biopsies captures the tumor’s functional state within precision oncology workflows, while advanced machine learning interprets multi protein signatures to estimate the likelihood of response and guide individualized treatment planning.

A dual-impact platform : treating today, discovering tomorrow

Beyond immediate choices, this approach reveals novel protein targets, stratifies patients for future studies and partnerships, and accelerates discovery alongside care.

Discover the science

Cupped hands gently holding a glowing, holographic liver with digital data overlays, symbolizing BeLiver's advanced, personalized approach to liver health and HCC treatment.

Interested in partnering with us?

We invite all stakeholders—clinicians, researchers, pharma companies, hospitals—to join BeLiver journey and build a unified front against cancer.

Connect with us